| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 4774 |
| 1 | METHOTREXATE SODIUM | 4168 |
| 2 | ETANERCEPT | 3947 |
| 3 | APREMILAST | 3932 |
| 4 | METHOTREXATE | 3911 |
| 5 | ADALIMUMAB | 3450 |
| 6 | RITUXIMAB | 3332 |
| 7 | TREPROSTINIL | 2818 |
| 8 | INFLIXIMAB | 2642 |
| 9 | ACETAMINOPHEN | 2483 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROSEMARY OIL | 27 | 0.5192 |
| 1 | LETIBOTULINUMTOXINA-WLBG | 143 | 0.4881 |
| 2 | ANTIBACTERIAL HAND WIPES | 113 | 0.3383 |
| 3 | BENZALKONIUM CHLORIDE 0.13% | 113 | 0.3005 |
| 4 | BORIC ACID | 106 | 0.2986 |
| 5 | BENZALKONIUM CHLORIDE | 113 | 0.2574 |
| 6 | TRIPROLIDINE HYDROCHLORIDE | 43 | 0.2205 |
| 7 | TRIAMCINOLONE HEXACETONIDE | 55 | 0.2099 |
| 8 | GOLIMUMAB | 1625 | 0.1290 |
| 9 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 79 | 0.1201 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 9093 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 6105 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4992 |
| 3 | Phosphodiesterase 4 Inhibitor [EPC] | 3955 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 3950 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 3585 |
| 6 | Prostacycline Vasodilator [EPC] | 2858 |
| 7 | Vitamin C [EPC] | 2646 |
| 8 | Benzodiazepine [EPC] | 2461 |
| 9 | Aminosalicylate [EPC] | 2368 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 179 | 0.2602 |
| 1 | Provitamin D2 Compound [EPC] | 2057 | 0.0691 |
| 2 | Adrenocorticotropic Hormone [EPC] | 52 | 0.0581 |
| 3 | Endoglycosidase [EPC] | 104 | 0.0561 |
| 4 | Interleukin-17A Antagonist [EPC] | 2029 | 0.0544 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 72 | 0.0404 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 223 | 0.0381 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 331 | 0.0380 |
| 8 | Human Immunoglobulin G [EPC] | 619 | 0.0294 |
| 9 | Hematopoietic Stem Cell Mobilizer [EPC] | 41 | 0.0276 |